economybharat.com

We Can Cover You
Click here
Facebook Youtube Instagram Linkedin
13
13

interim

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss OG_NewsReleaseCompanyLogo_93126.jpg

Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss

creativebharatgroup@gmail.com January 14, 2025
Zug, Switzerland:    Three-month interim data from first-of-its-kind trial demonstrate that the...
Read More Read more about Galderma Premieres Positive Interim Results Demonstrating the Efficacy of Its Injectable Aesthetics Portfolio in Addressing Facial Volume Loss as a Result of Medication-driven Weight Loss
MUVON Therapeutics Clears Phase 2 Interim Milestone and Will Participate in the 2025 J.P. Morgan Healthcare Conference 9d47b0d6cde707e1_400x400ar.jpeg

MUVON Therapeutics Clears Phase 2 Interim Milestone and Will Participate in the 2025 J.P. Morgan Healthcare Conference

creativebharatgroup@gmail.com January 9, 2025
PRESS RELEASE   Zurich, Switzerland, January 9, 2025 – MUVON Therapeutics AG,...
Read More Read more about MUVON Therapeutics Clears Phase 2 Interim Milestone and Will Participate in the 2025 J.P. Morgan Healthcare Conference